These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?]. Hansen PB; Jensen MK Ugeskr Laeger; 2007 Jun; 169(23):2187-9. PubMed ID: 17592682 [TBL] [Abstract][Full Text] [Related]
16. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R; Hagenbeek A Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [TBL] [Abstract][Full Text] [Related]
17. [Non-cytostatic treatment of malignancies. Anti-CD20 monoclonal antibody (Rituximab, Mabthera) in the treatment of non-Hodgkin's lymphoma]. Mayer J; Navrátil M; Vásová J; Vorlícek J Vnitr Lek; 2001 Sep; 47 Suppl 1():57-62. PubMed ID: 11693064 [TBL] [Abstract][Full Text] [Related]
18. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group. Hiddemann W; Unterhalt M; Pott C; Wörmann B; Sandford D; Freund M; Engert A; Gassmann W; Holtkamp W; Seufert J Semin Oncol; 1993 Oct; 20(5 Suppl 7):28-31. PubMed ID: 8235693 [TBL] [Abstract][Full Text] [Related]
19. [Rituximab in the treatment of indolent non-Hodgkin's lymphoma]. Aurer I; Mitrović Z; Radman I; Kovacević-Metelko J; Nemet D; Serventi-Seiwerth R; Stern-Padovan R; Jakic-Razumović J; Nola M; Zupancić-Salek S; Sertić D; Labar B Lijec Vjesn; 2004; 126(11-12):307-11. PubMed ID: 16082888 [TBL] [Abstract][Full Text] [Related]
20. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas. Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858 [No Abstract] [Full Text] [Related] [Next] [New Search]